Skip to main content
[Preprint]. 2020 Dec 21:2020.10.18.344622. [Version 2] doi: 10.1101/2020.10.18.344622

Table 1.

BLI kinetics for immobilized sACE22-IgG1 binding to coronavirus RBDs

CoV straina Wild type sACE22-IgG1b sACE22.v2.4-IgG1
kon (M−1 s−1) koff(s−1) KD (nM) χ2 c kon (M−1 s−1) koff(s−1) KD (nM) χ2
LYRa11 8.7 × 105 7.9 × 10−2 91 0.12 1.4 × 106 2.5 × 10−3 1.8 0.10
Rs7327 6.4 × 105 4.0 × 10−2 63 0.25 9.8 × 105 1.8 × 10−3 1.9 0.11
Rs4231 3.2 × 105 2.2 × 10−2 69 0.04 4.5 × 105 1.6 × 10−3 3.5 0.10
Rs4084 2.9 × 105 2.5 × 10−2 85 0.24 4.8 × 105 1.5 × 10−3 3.1 0.10
RsSHC014 8.8 × 105 2.6 × 10−2 29 0.20 1.6 × 106 2.0 × 10−3 1.3 0.29
SARS-1 6.6 × 103 1.2 × 10−4 58 0.03 3.0 × 103 5.6 × 10−6 2.1 0.03
SARS-2 1.4 × 106 8.1 × 10−3 16 0.25 6.6 × 105 2.8 × 10−4 0.4 0.09
SARS-2 (Y449K) 2.0 × 106 9.0 × 10−2 46 0.67 4.3 × 106 4.0 × 10−3 0.9 0.71
SARS-2 (N501W) 2.4 × 106 5.4 × 10−3 2.3 0.43 3.3 × 106 2.8 × 10−4 0.1 0.23
SARS-2 (N501Y) 2.2 × 106 1.8 × 10−3 0.8 0.15 3.6 × 105 1.1 × 10−4 < 0.1 0.24
a

Purified RBDs at 5 to 7 concentrations were used as the soluble analytes.

b

IgG1-Fc fused sACE22 was immobilized to anti-human IgG Fc capture biosensors.

c

χ2 values represent the goodness of curve fitting. Acceptable values were considered to be less than 3.